» Articles » PMID: 23210930

Digitoxin and Its Analogs As Novel Cancer Therapeutics

Overview
Publisher Biomed Central
Specialty Hematology
Date 2012 Dec 6
PMID 23210930
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of evidence indicates that digitoxin cardiac glycoside is a promising anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half-life and a well-established clinical profile. New scientific avenues have shown that manipulating the chemical structure of the saccharide moiety of digitoxin leads to synthetic analogs with increased cytotoxic activity. However, the anticancer mechanism of digitoxin or synthetic analogs is still subject to study while concerns about digitoxin's cardiotoxicity preclude its clinical application in cancer therapeutics. This review focuses on digitoxin and its analogs, and their cytotoxicity against cancer cells. Moreover, a new perspective on the pharmacological aspects of digitoxin and its analogs is provided to emphasize new research directions for developing potent chemotherapeutic drugs.

Citing Articles

Advanced Technologies for Large Scale Supply of Marine Drugs.

Martinez H, Santos M, Pedraza L, Testera A Mar Drugs. 2025; 23(2).

PMID: 39997193 PMC: 11857447. DOI: 10.3390/md23020069.


Incredible use of plant-derived bioactives as anticancer agents.

Kangra K, Kakkar S, Mittal V, Kumar V, Aggarwal N, Chopra H RSC Adv. 2025; 15(3):1721-1746.

PMID: 39835210 PMC: 11744461. DOI: 10.1039/d4ra05089d.


Pharmacodynamic characterization and evaluation of oxidative stress effects of digitoxigenin derivatives on HeLa cells.

Valadares J, Azalim-Neto P, Liu X, Carrozza N, ODoherty G, Quintas L J Membr Biol. 2025; 258(1):63-73.

PMID: 39812699 DOI: 10.1007/s00232-024-00334-z.


Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses.

Kibria M, Ali M, Haque Mollah M PLoS One. 2024; 19(11):e0312493.

PMID: 39585882 PMC: 11588272. DOI: 10.1371/journal.pone.0312493.


Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma.

Chang C, Li L, Su L, Yang F, Zha Q, Sun M Adv Sci (Weinh). 2024; 11(35):e2403387.

PMID: 39018261 PMC: 11425265. DOI: 10.1002/advs.202403387.


References
1.
Sreenivasan Y, Raghavendra P, Manna S . Oleandrin-mediated expression of Fas potentiates apoptosis in tumor cells. J Clin Immunol. 2006; 26(4):308-22. DOI: 10.1007/s10875-006-9028-0. View

2.
Di Florio A, Capurso G, Milione M, Panzuto F, Geremia R, Delle Fave G . Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer. 2007; 14(1):111-24. DOI: 10.1677/erc.1.01318. View

3.
WILLIAMS Jr J, POTTER R, Mathew B . Effects of arrhythmia-producing concentrations of digitoxin on mechanical performance of cat myocardium. Am Heart J. 1983; 105(1):21-5. DOI: 10.1016/0002-8703(83)90273-9. View

4.
Bielawski K, Winnicka K, Bielawska A . Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A. Biol Pharm Bull. 2006; 29(7):1493-7. DOI: 10.1248/bpb.29.1493. View

5.
Chen C, Chang C, Liu H, Liao M, Chang C, Hsu J . Apoptosis induction in BEFV-infected Vero and MDBK cells through Src-dependent JNK activation regulates caspase-3 and mitochondria pathways. Vet Res. 2009; 41(2):15. PMC: 2785050. DOI: 10.1051/vetres/2009063. View